prikaz prve stranice dokumenta The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
  Preuzmi
PDF 783.78 KB
Znanstveni rad - Pregledni rad
The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
Medicina, 60 (2024), 3; 477. https://doi.org/10.3390/medicina60030477
Kirigin Biloš, Lora Stanka; Altabas, Velimir; Vukić Dugac, Andrea; Baretić, Maja

Citiranost:
,
Citirajte ovaj rad

Kirigin Biloš, L. S., Altabas, V., Vukić Dugac, A. i Baretić, M. (2024). The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina, 60. (3). doi: 10.3390/medicina60030477

Kirigin Biloš, Lora Stanka, et al. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina, vol. 60, br. 3, 2024. https://doi.org/10.3390/medicina60030477

Kirigin Biloš, Lora Stanka, Velimir Altabas, Andrea Vukić Dugac i Maja Baretić. "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis." Medicina 60, br. 3 (2024). https://doi.org/10.3390/medicina60030477

Kirigin Biloš, L. S., et al. (2024) 'The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis', Medicina, 60(3). doi: 10.3390/medicina60030477

Kirigin Biloš LS, Altabas V, Vukić Dugac A, Baretić M. The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis. Medicina [Internet]. 14.03.2024. [pristupljeno 07.04.2025.];60(3). doi: 10.3390/medicina60030477

L. S. Kirigin Biloš, V. Altabas, A. Vukić Dugac i M. Baretić, "The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis", Medicina, vol. 60, br. 3, Ožujak 2024. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:761419. [Citirano: 07.04.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:761419
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)The Role of Continuous Glucose Monitoring in Detecting Early Dysglycemia and Clinical Outcomes in Patients with Cystic Fibrosis
AutorLora Stanka Kirigin Biloš
AutorVelimir Altabas
AutorAndrea Vukić Dugac
AutorMaja Baretić
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in patients with cystic fibrosis (CF). CFRD has been correlated with important clinical outcomes, including poor nutrition, reduced pulmonary function, and earlier mortality. However, clinical decline due to abnormalities of blood glucose (dysglycemia) begins early in CF, before the diagnosis of CFRD by the gold-standard oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) has been validated in patients... Više with CF and has been recognized as a valuable tool in detecting early glucose abnormalities in patients with CF. Several CGM parameters have been used to predict CFRD in some but not all studies, and there is no consensus regarding CGM use for diagnostic purposes. Thus, it remains a complementary test to OGTT in CFRD diagnosis. The aim of this review is to provide an update on the pathophysiological mechanisms of CFRD, recent advances in the use of CGM for CFRD screening, and the association between CGM measures and CF-related clinical outcomes. Sakrij dio sažetka
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMedicina
Brojčani podacivol. 60, br. 3, 477
e-ISSN1648-9144
DOIhttps://doi.org/10.3390/medicina60030477
URN:NBNurn:nbn:hr:105:761419
Datum objave publikacije2024-03-14
URL dokumentahttps://www.mdpi.com/1648-9144/60/3/477
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-09-30 08:08:34
accessibility

closePristupačnostrefresh

Ako želite spremiti trajne postavke, kliknite Spremi, ako ne - vaše će se postavke poništiti kad zatvorite preglednik.